Su–Chun Cheng

2.4k total citations
61 papers, 1.4k citations indexed

About

Su–Chun Cheng is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Su–Chun Cheng has authored 61 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 15 papers in Radiology, Nuclear Medicine and Imaging and 14 papers in Oncology. Recurrent topics in Su–Chun Cheng's work include Medical Imaging Techniques and Applications (9 papers), Renal cell carcinoma treatment (8 papers) and Ovarian cancer diagnosis and treatment (7 papers). Su–Chun Cheng is often cited by papers focused on Medical Imaging Techniques and Applications (9 papers), Renal cell carcinoma treatment (8 papers) and Ovarian cancer diagnosis and treatment (7 papers). Su–Chun Cheng collaborates with scholars based in United States, Finland and China. Su–Chun Cheng's co-authors include Max Wintermark, Sabina Signoretti, Jason Hom, Monica Marabelli, Michael B. Atkins, Giovanni Parmigiani, Toni K. Choueiri, Joerg Bredno, David F. McDermott and Rupal S. Bhatt and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Journal of the American College of Cardiology.

In The Last Decade

Su–Chun Cheng

58 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Su–Chun Cheng United States 17 428 376 338 311 284 61 1.4k
Uta Reichelt Germany 24 710 1.7× 313 0.8× 257 0.8× 419 1.3× 164 0.6× 47 1.4k
Patrick D. Kelly United States 21 298 0.7× 403 1.1× 294 0.9× 265 0.9× 304 1.1× 83 1.7k
Young Kwok United States 24 587 1.4× 747 2.0× 587 1.7× 253 0.8× 544 1.9× 100 2.1k
Alexander Claviez Germany 26 751 1.8× 368 1.0× 191 0.6× 343 1.1× 462 1.6× 80 2.1k
Antonio Travaglino Italy 38 424 1.0× 446 1.2× 447 1.3× 464 1.5× 60 0.2× 191 3.5k
Kenneth Tou En Chang Singapore 22 341 0.8× 591 1.6× 156 0.5× 340 1.1× 102 0.4× 144 1.8k
Sheila Aparecida Coelho Siqueira Brazil 22 438 1.0× 283 0.8× 327 1.0× 223 0.7× 183 0.6× 103 1.3k
Joseph G. Pressey United States 23 512 1.2× 478 1.3× 123 0.4× 550 1.8× 189 0.7× 72 1.5k
Joachim Kühl Germany 24 438 1.0× 409 1.1× 270 0.8× 609 2.0× 596 2.1× 59 2.1k
Brian Weiss United States 22 218 0.5× 236 0.6× 232 0.7× 440 1.4× 774 2.7× 67 1.5k

Countries citing papers authored by Su–Chun Cheng

Since Specialization
Citations

This map shows the geographic impact of Su–Chun Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su–Chun Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su–Chun Cheng more than expected).

Fields of papers citing papers by Su–Chun Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su–Chun Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su–Chun Cheng. The network helps show where Su–Chun Cheng may publish in the future.

Co-authorship network of co-authors of Su–Chun Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Su–Chun Cheng. A scholar is included among the top collaborators of Su–Chun Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su–Chun Cheng. Su–Chun Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Konstantinopoulos, Panagiotis A., Elizabeth K. Lee, Carolyn Krasner, et al.. (2025). Serial Circulating Tumor DNA Sequencing to Monitor Response and Define Acquired Resistance to Letrozole/Abemaciclib in Endometrial Cancer. JCO Precision Oncology. 9(9). e2400882–e2400882.
2.
Konstantinopoulos, Panagiotis A., Mingyang Cai, Niya Xiong, et al.. (2024). Serial circulating tumor DNA (ctDNA) sequencing to monitor response and define acquired resistance to letrozole/abemaciclib in endometrial cancer (EC).. Journal of Clinical Oncology. 42(16_suppl). 5592–5592.
4.
Jacene, Heather A., Pamela J. DiPiro, Jennifer R. Bellon, et al.. (2020). Discrepancy between FDG-PET/CT and contrast-enhanced CT in the staging of patients with inflammatory breast cancer: implications for treatment planning. Breast Cancer Research and Treatment. 181(2). 383–390. 19 indexed citations
5.
Lee, Elizabeth K., Niya Xiong, Su–Chun Cheng, et al.. (2020). Combined pembrolizumab and pegylated liposomal doxorubicin in platinum resistant ovarian cancer: A phase 2 clinical trial. Gynecologic Oncology. 159(1). 72–78. 64 indexed citations
7.
Qin, Lei, Jinrong Qu, Katherine L. Reinshagen, et al.. (2018). Normalization of ADC does not improve correlation with overall survival in patients with high-grade glioma (HGG). Journal of Neuro-Oncology. 137(2). 313–319. 15 indexed citations
8.
Erbe, Amy K., Wei Wang, Jacob L. Goldberg, et al.. (2016). FCGR Polymorphisms Influence Response to IL2 in Metastatic Renal Cell Carcinoma. Clinical Cancer Research. 23(9). 2159–2168. 12 indexed citations
9.
Mahoney, Kathleen M., Susanna Jacobus, Rupal S. Bhatt, et al.. (2016). Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell Carcinoma. Clinical Genitourinary Cancer. 14(4). 304–313.e6. 9 indexed citations
10.
Callea, Marcella, Laurence Albigès, Mamta Gupta, et al.. (2015). Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell Carcinoma. Cancer Immunology Research. 3(10). 1158–1164. 266 indexed citations
11.
Kartoun, Uri, Su–Chun Cheng, Sheng Yu, et al.. (2015). Demonstrating the Advantages of Applying Data Mining Techniques on Time-Dependent Electronic Medical Records.. AMIA. 4 indexed citations
12.
Cheng, Su–Chun, Ying Huang, Nancy E. Kohl, et al.. (2015). [18F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of LAPC4-CR Castration-Resistant Prostate Cancer Xenograft Model in Soft Tissue Compartments. Translational Oncology. 8(3). 147–153. 4 indexed citations
13.
Ananthakrishnan, Ashwin N., Andrew Cagan, Vivian S. Gainer, et al.. (2014). Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease. DSpace@MIT (Massachusetts Institute of Technology). 1 indexed citations
14.
Kumar, Vishesh, Su–Chun Cheng, Sheng Yu, et al.. (2014). NATURAL LANGUAGE PROCESSING IMPROVES PHENOTYPIC ACCURACY IN AN ELECTRONIC MEDICAL RECORD COHORT OF TYPE 2 DIABETES AND CARDIOVASCULAR DISEASE. Journal of the American College of Cardiology. 63(12). A1359–A1359. 13 indexed citations
15.
Ananthakrishnan, Ashwin N., Su–Chun Cheng, Tianxi Cai, et al.. (2013). Association Between Reduced Plasma 25-Hydroxy Vitamin D and Increased Risk of Cancer in Patients With Inflammatory Bowel Diseases. DSpace@MIT (Massachusetts Institute of Technology). 4 indexed citations
16.
Ananthakrishnan, Ashwin N., Tianxi Cai, Guergana Savova, et al.. (2013). Improving Case Definition of Crohnʼs Disease and Ulcerative Colitis in Electronic Medical Records Using Natural Language Processing. DSpace@MIT (Massachusetts Institute of Technology). 2 indexed citations
17.
Ananthakrishnan, Ashwin N., Andrew Cagan, Vivian S. Gainer, et al.. (2013). Normalization of Plasma 25-Hydroxy Vitamin D Is Associated with Reduced Risk of Surgery in Crohn’s Disease. DSpace@MIT (Massachusetts Institute of Technology). 9 indexed citations
18.
Choueiri, Toni K., Su–Chun Cheng, Angela Qu, et al.. (2012). Carbonic anhydrase IX as a potential biomarker of efficacy in metastatic clear-cell renal cell carcinoma patients receiving sorafenib or placebo: Analysis from the treatment approaches in renal cancer global evaluation trial (TARGET). Urologic Oncology Seminars and Original Investigations. 31(8). 1788–1793. 40 indexed citations
19.
Schneider, Thomas, Jason Hom, Joerg Bredno, et al.. (2010). Delay Correction for the Assessment of Blood-Brain Barrier Permeability Using First-Pass Dynamic Perfusion CT. American Journal of Neuroradiology. 32(7). E134–E138. 10 indexed citations
20.
Kidd, Pamela G., et al.. (1993). Prediction of CD4 count from CD4 percentage experience from three laboratories. AIDS. 7(7). 933–933. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026